Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: An updated meta-analysis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Wei, Fang ^a   Liu, Junying ^b   Liu, Fen ^a   Hu, Huaidong ^a   Ren, Hong ^a   Hu, Peng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b Zhoukou Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; INTERFERON; MEPREDNISONE; MIZORIBINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PEGINTERFERON; PREDNISOLONE; PREDNISONE; RAPAMYCIN; RIBAVIRIN; STEROID; TACROLIMUS; ANTIVIRUS AGENT;

ADULT; ALOPECIA; ANEMIA; ANOREXIA; ANTIVIRAL THERAPY; ARTICLE; BACKACHE; COMBINATION CHEMOTHERAPY; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLU LIKE SYNDROME; GRAFT RECIPIENT; GRAFT REJECTION; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; MONOTHERAPY; NONHUMAN; OUTCOME ASSESSMENT; PAPILLEDEMA; PATIENT COMPLIANCE; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; TREATMENT WITHDRAWAL; UROSEPSIS; CLINICAL TRIAL (TOPIC); COMPLICATION; DRUG EFFECTS; HEPACIVIRUS; KIDNEY DISEASES; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; CLINICAL TRIALS AS TOPIC; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERONS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 84899057323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0090611     Document Type: Article

References (81)

1. World Health Organization (2002) Hepatitis C 2002. In: Resource Centre Communicable Diseases. Available: http://www.who.int/ith/chapter05-m05- hepatitisc.html. Accessed 2005 February 14.
2. Heintges T, Wands JR (1997) Hepatitis C virus: epidemiology and transmission. Hepatology 26: 521-526. (Pubitemid 27392339)
3. Martin P, Fabrizi F (2008) Hepatitis C virus and kidney disease. Journal of Hepatology 49: 613-624.
4. Scott DR, Wong JK, Spicer TS, Dent H, Mensah FK, et al. (2010) Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand. Transplantation 90: 1165-1171.
5. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, et al. (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 80: 17-28.
6. Pereira BJ, Levey AS (1997) Hepatitis C virus infection in dialysis and renal transplantation. Kidney Int 51: 981-999. (Pubitemid 27186522)
7. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH (2003) Hepatitis C and renal disease: an update. Am J Kidney Dis 42: 631-657. (Pubitemid 37187365)
8. Periera BJ, Wright TL, Schmid CH, Levey AS (1995) The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 60: 799-805.
9. Mitwalli AH, Alam A, Al-Wakeel J, Al Suwaida K, Tarif N, et al. (2006) Effect of chronic viral hepatitis on graft survival in Saudi renal transplant patients. Nephron Clin Pract 102: c72-80. (Pubitemid 43087564)
10. Rostaing L, Weclawiak H, Izopet J, Kamar N (2012) Treatment of hepatitis C virus infection after kidney transplantation. Contrib Nephrol 176: 87-96.
11. Fabrizi F, Martin P, Ponticelli C (2001) Hepatitis C virus infection and renal transplantation. American Journal of Kidney Diseases 38: 919-934. (Pubitemid 33022168)
12. Morales JM, Campistol JM, Dominguez-Gil B (2002) Hepatitis C virus infection and kidney transplantation. Semin Nephrol 22: 365-374. (Pubitemid 34790833)
13. Morales JM, Dominguez-Gil B, Sanz-Guajardo D, Fernandez J (2004) The influence of hepatitis B and hepatitis C virus infection in the recipient on late renal allograft failure. 19 Suppl 3: iii72-76.
14. Cruzado JM, Carrera M, Torras J, Grinyo JM (2001) Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 1: 171-178. (Pubitemid 33674158)
15. Seron D, Arias M, Campistol JM, Morales JM (2003) Late renal allograft failure between 1990 and 1998 in Spain: a changing scenario. Transplantation 76: 1588-1594. (Pubitemid 37549832)
16. Kim E, Ko HH, Yoshida EM (2011) Treatment issues surrounding hepatitis C in renal transplantation: A review. Annals of Hepatology 10: 5-14.
17. [No authors listed] (2004) Viral hepatitis guidelines in hemodialysis and transplantation. Am J Transplant 4 Suppl 10: 72-82.
18. Fabrizi F, Lunghi G, Dixit V, Martin P (2006) Meta-analysis: anti-viral therapy of hepatitis C virus-related liver disease in renal transplant patients. Aliment Pharmacol Ther 24: 1413-1422. (Pubitemid 44657117)
19. Ichikawa Y, Kyo M, Hanafusa T, Kohro T, Kishikawa H, et al. (1998) A 20-year case study of a kidney transplant recipient with chronic active hepatitis C - Clinical course and successful treatment for late acute rejection induced by interferon therapy. Transplantation 65: 134-138. (Pubitemid 28100446)
20. Toth CM, Pascual M, Chung RT, Graeme-Cook F, Dienstag JL, et al. (1998) Hepatitis C virus-associated fibrosing cholestatic hepatitis after renal transplantation: response to interferon-alpha therapy. Transplantation 66: 1254-1258. (Pubitemid 28530333)
21. Luciani G, Bossola M, Muscaritoli M, Panocchia N, Ferrante A, et al. (2003) Sustained response with negative serum HCV-mRNA and disappearance of antibodies after interferon-alpha therapy in a kidney transplant recipient with chronic active viral hepatitis C. J Nephrol 16: 417-420. (Pubitemid 36773192)
22. Konishi I, Horiike N, Michitaka K, Ochi N, Furukawa S, et al. (2004) Renal transplant recipient with chronic hepatitis C who obtained sustained viral response after interfon-(beta) therapy. Internal Medicine 43: 931-934. (Pubitemid 39534796)
23. Fraile P, Garcia-Cosmes P, Rosado C, Tabernero JM (2009) Interferon-alpha and its deleterious effects on kidney transplant: regarding one case. Nefrologia 29: 366-367.
24. Tokumoto T, Tanabe K, Oshima T, Ishikawa N, Shinmura H, et al. (1999) Outcome of interferon-alpha (IFN-alpha) treatment in hemodialysis patients and renal transplant recipients with chronic hepatitis C. Transplantation 67: S99-S99.
25. Kim HW, Choi BS, Park JH, Yang CW, Kim YS, et al. (2001) Clinical outcome of Recombinant Interferon-alpha treatment in pre- and post-transplant patients. Journal of the American Society of Nephrology 12: 901A-901A.
26. Sanchez W, Brandhagen DJ, Cosio FG, Poterucha JJ, Gross JB, et al. (2005) Safety and tolerability of interferon for the treatment of chronic HCV in renal transplant recipients. American Journal of Transplantation 5: 301-302.
27. Weclawiak H, Kamar N, Modesto A, Izopet J, Sallusto F, et al. (2007) Acute renal allograft rejection following alpha-interferon therapy for chronic hepatitis C infection in renal transplant patients with failed allografts. Nephrology Dialysis Transplantation 22: 203-203.
28. Kim YK, Yoon HE, Kim SH, Choi BS, Kim Y-s, et al. (2008) Efficacy and safety of interferon alpha treatment in kidney transplant recipients with chronic hepatitis C. American Journal of Transplantation 8: 567-568.
29. Caeiro F, Baptista V, Rodrigues N, Carvalho D, Aires I, et al. (2011) Treatment of hepatitis C virus infection in kidney transplant recipients: Case report. Transplantation Proceedings 43: 259-262.
30. Mukherjee S, Ariyarantha K (2007) Successful Hepatitis C Eradication With Preservation of Renal Function in a Liver/kidney Transplant Recipient Using Pegylated Interferon and Ribavirin. Transplantation 84: 1374-1375. (Pubitemid 351339330)
31. Fujiwara K, Goto N, Tanaka Y, Hayashi K, Yamada T, et al. (2011) Successful treatment of renal transplant recipients infected with chronic hepatitis C genotype 2 with peg-interferon and ribavirin combination therapy. Hepatology 54 SUPPL. 1: 839A.
32. Fujiwara K, Goto N, Hayashi K, Yamada T, Ban T, et al. (2012) Treatment of renal transplant recipients infected with chronic hepatitis C with peg-interferon and ribavirin combination therapy. Hepatology 56 SUPPL. 1: 1047A.
33. Dersimonian R, Laird N (1986) Meta-analysis in clinical trials. control clin Trials 7: 177-178.
34. Petitti DB (2001) Approaches to heterogeneity in meta-analysis. Stat Med 20: 3625-3633.
35. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
36. Ozminkowski RJ, Wortman PM, Roloff DW (1988) Inborn/outborn status and neonatal survival: a meta-analysis of non-randomized studies. Stat Med 7: 1207-1221. (Pubitemid 19018451)
37. Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573. (Pubitemid 34746063)
38. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. (Pubitemid 27387172)
39. Siddiqui AR, Abbas Z, Luck NH, Hassan SM, Aziz T, et al. (2012) Experience of fibrosing cholestatic hepatitis with hepatitis C virus in kidney transplant recipients. Transplant Proc 44: 721-724.
40. Sanai FM, Mousa DH, Aleid H, Al Shoail G, Al Mdani AS, et al. (2010) Peginterferon ALFA-2A plus ribavirin combination treatment in chronic hepatitis C postrenal transplant patients: An interim analysis. Hepatology 52 SUPPL. 1: 789A.
41. Kotanko P, Raid H, Skrabal F (2001) Hepatitis C associated cryoglobulinemic vasculitis post-transplant: Efficacy of low-dose interferon alpha and ribavirin therapy. Journal of the American Society of Nephrology 12: 936A-936A.
42. Alfurayh O, Chaaban A, Pall A, Al Mutawa N, Ellis M, et al. (2002) Long-term follow up of haemodialysis (hd) patients with chronic hepatitis C (hcv) infection - favorable outcome with a-interferon (ifn) followed by kidney transplantation [abstract no: M221]. Nephrology Dialysis Transplantation. pp. 110.
43. Pageaux G-P, Mourad G, Chermak F, Audin H, Garrigue V, et al. (2006) Late treatment of chronic hepatitis C in renal transplant recipients: An open pilot study. Hepatology 44: 331A-331A.
44. Scott DR, Wong JK, Spicer ST, Dent H, Levy MT (2008) Hepatitis C in Dialysis and Renal Transplant Patients - Analysis of the Australia and New Zealand Dialysis and Transplant Registry Reveals Significant Impact of Hepatitis C Infection after Renal Transplantation. Hepatology 48: 1130A-1130A.
45. Abbas Z, Urrehman A, Hassan Luck N, Hassan SM, Mubarak M, et al. (2012) Fibrosing cholestatic hepatitis C in kidney transplant recipients. Hepatology International 6: 150.
46. Rostaing L, Izopet J, Arnaud C, Cisterne JM, Alric L, et al. (1999) Long-term impact of superinfection by hepatitis G virus in hepatitis C virus-positive renal transplant patients. Transplantation 67: 556-560. (Pubitemid 29114218)
47. Ridruejo E, Diaz C, Davalos Michel M, Soler Pujol G, Martinez A, et al. (2010) Short and long term outcome of kidney transplanted patients with chronic viral hepatitis B and C. Annals of Hepatology 9: 271-277.
48. Schmitz V, Kiessling A, Bahra M, Puhl G, Kahl A, et al. (2007) Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation. Ann Transplant 12: 22-27.
49. Van Wagner LB, Baker T, Ahya SN, Norvell JP, Wang E, et al. (2009) Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation. Journal of Hepatology 51: 874-880.
50. Molina E, Blum-Guzman JP, Arosemena L, Moon J, Tzakis AG, et al. (2010) Outcomes of Simultaneous Liver and Kidney Transplant Recipients in Hepatitis C Infected Patients. Hepatology 52: 872A-873A.
51. Cimsit B, Schilsky M, Moini M, Cartiera K, Arvelakis A, et al. (2011) Combined liver kidney transplantation: Critical analysis of a single-center experience. Transplantation Proceedings 43: 901-904.
52. Hassan Q, Roche B, Buffet C, Bessede T, Samuel D, et al. (2012) Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha. Transplant International 25: 941-947.
53. Kamar N, Toupance O, Buchler M, Sandres-Saune K, Izopet J, et al. (2003) Evidence that clearance of hepatitis C virus RNA after (alpha)-interferon therapy in dialysis patients is sustained after renal transplantation. Journal of the American Society of Nephrology 14: 2092-2098. (Pubitemid 36909917)
54. Voiculescu M, Ionescu C, Ismail G, Mandache E, Hortopan M, et al. (2003) Acute pancreatitis, acute hepatitis and acute renal failure favourably resolved in two renal transplant recipients. Romanian Journal of Gastroenterology 12: 41-46. (Pubitemid 36433042)
55. Carbognin SJ, Solomon NM, Yeo FE, Swanson SJ, Bohen EM, et al. (2006) Acute renal allograft rejection following pegylated IFN-(alpha) treatment for chronic HCV in a repeat allograft recipient on hemodialysis: A case report. American Journal of Transplantation 6: 1746-1751. (Pubitemid 43945820)
56. Fabriz F, Martin P (2006) Management of hepatitis B and C virus infection before and after renal transplantation. Current Opinion in Organ Transplantation 11: 583-588.
57. Montalbano M, Pasulo L, Sonzogni A, Remuzzi G, Colledan M, et al. (2007) Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe-cryoglobulinemia in a liver/kidney transplant recipient. Journal of Clinical Gastroenterology 41: 216-220. (Pubitemid 46148666)
58. Sperl J, Petrasek J, Spicak J, Viklicky O (2008) Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon-alpha 2a. J Hepatol 49: 461-462; author reply 462-463.
59. Dale CH, Burns P, McCutcheon M, Hernandez-Alejandro R, Marotta PJ (2009) Spontaneous clearance of hepatitis C after liver and renal transplantation. Canadian Journal of Gastroenterology 23: 265-267.
60. Chang M-L, Lai P-C, Yeh C-T (2011) Sustained eradication of hepatitis C virus by low-dose long-term interferon therapy in a renal transplant recipient with dual infection with hepatitis B and C viruses: a case report. Journal of Medical Case Reports 5: 246-246.
61. Izopet J, Rostaing L, Ton-That H, Dubois M, Cazabat M, et al. (1997) Kinetics of HCV viremia in kidney transplant recipients during and after (alpha)-interferon therapy. American Journal of Nephrology 17: 417-420. (Pubitemid 27425094)
62. Yasumura T, Nakajima H, Hamashima T, Nakai I, Yoshimura N, et al. (1997) Long-term outcome of recombinant INF-alpha treatment of chronic hepatitis C in kidney transplant recipients. Transplant Proc 29: 784-786. (Pubitemid 27125961)
63. Durlik M, Gaciong Z, Rowinska D, Rancewicz Z, Lewandowska D, et al. (1998) Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients. Transplant international : official journal of the European Society for Organ Transplantation 11 Suppl 1: S135-139.
64. Hanafusa T, Ichikawa Y, Yazawa K, Kishikawa H, Fukunishi T, et al. (1998) Hepatitis C virus infection in kidney transplantation and a pilot study of the effects of interferon-alpha therapy. Transplant Proc 30: 122-124. (Pubitemid 28090335)
65. Tokumoto T, Tanabe K, Ishikawa N, Simizu T, Oshima T, et al. (1998) Effect of interferon-alfa treatment in renal transplant recipients with chronic hepatitis C. Transplant Proc 30: 3270-3272. (Pubitemid 28538804)
66. Baid S, Tolkoff-Rubin N, Saidman S, Chung R, Williams WW, et al. (2003) Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. American Journal of Transplantation 3: 74-78. (Pubitemid 36306827)
67. Tang S, Cheng IKP, Leung VKS, Kuok UI, Tang AWC, et al. (2003) Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin. Journal of Hepatology 39: 875-878. (Pubitemid 37372201)
68. Shu KH, Lan JL, Wu MJ, Cheng CH, Chen CH, et al. (2004) Ultra-low dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients. American Journal of Transplantation 4: 205-205.
69. Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, et al. (2006) Chronic hepatitis C virus infection in renal transplant: Treatment and outcome. Clinical Transplantation 20: 677-683. (Pubitemid 44712266)
70. Pageaux G-P, Hilleret M-N, Garrigues V, Bismuth M, Audin-Mamlouk H, et al. (2009) Pegylated interferon-alpha-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study. Transplant International 22: 562-567.
71. Aljumah AA, Saeed MA, Al Flaiw AI, Al Traif IH, Al Alwan AM, et al. (2012) Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipients. World Journal of Gastroenterology 18: 55-63.
72. Sanai FM, Mousa D, Al-Mdani A, Al-Shoail G, Al-Ashgar H, et al. (2013) Safety and efficacy of peginterferon-(alpha)2a plus ribavirin treatment in renal transplant recipients with chronic hepatitis C. Journal of Hepatology.
73. Shepherd J, Brodin H, Cave C, Waugh N, Price A, et al. (2004) Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation. Health Technol Assess 8: iii-iv, 1-125.
74. Shepherd J, Waugh N, Hewitson P (2000) Combination therapy (interferon alfa and ribavirin) in the treatment of chronic hepatitis C: a rapid and systematic review. Health Technol Assess 4: 1-67.
75. Baid S, Cosimi AB, Tolkoff-Rubin N (2000) Renal disease associated with hepatitis C infection after kidney and liver transplantation. 70: 255-261.
76. Samuel D (2004) Hepatitis C, interferon, and risk of rejection after liver transplantation. Liver Transpl 10: 868-871.
77. Rostaing L (2000) Treatment of hepatitis C virus infection after renal transplantation: new insights. Nephrol Dial Transplant 15 Suppl 8: 74-76.
78. Kamar N, Rostaing L, Sandres-Saune K, Ribes D, Durand D, et al. (2004) Amantadine therapy in renal transplant patients with hepatitis C virus infection. J Clin Virol 30: 110-114. (Pubitemid 38457078)
79. Covic A, Abramowicz D, Bruchfeld A, Leroux-Roels G, Samuel D, et al. (2009) Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 24: 719-727.
80. Ozdemir BH, Ozdemir FN, Sezer S, Colak T, Haberal M (2006) De novo glomerulonephritis in renal allografts with hepatitis C virus infection. Transplant Proc 38: 492-495.
81. Wells JT, Lucey MR, Said A (2006) Hepatitis C in transplant recipients of solid organs, other than liver. Clin Liver Dis 10: 901-917. (Pubitemid 44880160)